HNN3.0
Register
Register
Register

Neurix

Company (SME)

www.neurix.ch/Geneva, Switzerland
32 profile visits

About

HUMAN CELLULAR MODEL SYSTEMS

For compound screening and neuroscience research

Neurix is bridging the Gap in Neuroscience Research

✓ Advanced, relevant in vitro cell models based on human iPSC (induced pluripotent stem cell)

material, replicating brain physiology and pathology.

✓ Preclinical testing using human tissue provides more reliable results, effectively bridging the gap

between lab research and successful clinical applications.

✓ Accelerating treatment development for brain diseases by offering solutions for drug discovery and

therapeutic validation.

Representatives

Scientific Strategy and Partnerships Lead

Neurix

Business development

Neurix

Marketplace (2)

  • Project cooperation

    Seeking partners on NAMs (organoids) preclinical drugs screen & technological development

    We develop brain organoids models for Alzheimer's disease, Parkinson's disease and glioblastoma.

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    Author

    Scientific Strategy and Partnerships Lead at Neurix

    Geneva, Switzerland

  • Project cooperation

    Seeking Partners for Parkinson´s Disease-focused project

    I would like to connect with academic or industry partners who have experience with Parkinson’s disease models.

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    Author

    Business development at Neurix

    Geneva, Switzerland